95 results
Page 5 of 5
6-K
EX-99.1
a5kyoew765ri
29 Mar 19
Current report (foreign)
6:02am
6-K
EX-99.1
dh85ybp024j36
29 Mar 19
Current report (foreign)
6:00am
6-K
EX-99.1
a7exwpnkkxrdkt5ot7
23 Oct 18
Positive Trial Results with Filgotinib In Psoriatic Arthritis and Ankylosing Spondylitis Both Published In the Lancet
7:59am
6-K
EX-99.1
jkqm06dc3a yye4hh
22 Oct 18
Phase 3 Data on Filgotinib In Biologic-experienced Rheumatoid Arthritis to Be Presented at 2018 Acr/arhp Annual Meeting
6:05am
6-K
EX-99.1
uurhmdyeatxlbxdbsg
11 Sep 18
Gilead and Galapagos Announce Filgotinib Meets Primary and All Key Secondary Endpoints In First Phase 3 Study In Rheumatoid Arthritis
12:00am
6-K
EX-99.1
t00mah1x7tmjcb yk2
5 Jun 18
Current report (foreign)
12:00am
6-K
EX-1.1
9x71i4aw00fu299su
18 Apr 17
Galapagos announces launch of proposed public offering
12:00am
20-F
9iato
25 Mar 16
Annual report (foreign)
12:00am
DRS/A
EX-10
e7nhq t8pe195
4 Mar 15
Draft registration statement (amended)
12:00am
DRS/A
EX-10
zg0jw
4 Mar 15
Draft registration statement (amended)
12:00am
DRS/A
ati1nf41h2o7ibwz8
4 Mar 15
Draft registration statement (amended)
12:00am
DRS
m6fhv1b8i txn
6 Feb 15
Draft registration statement
12:00am
DRS
EX-10
liphww2 k5t
6 Feb 15
Draft registration statement
12:00am